摘要 |
<p>The present invention belongs to the chemical and pharmaceutical field, in particular relates to a compound as shown in formula I which has a Hepatitis C virus inhibition activity or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug thereof, and a pharmaceutical composition comprising these compounds and the uses of these compounds or compositions in the preparation of drugs. The compound of the present invention has a good inhibitory effect on HCV.</p> |
申请人 |
NANJING SANHOME PHARMACEUTICAL CO., LTD. |
发明人 |
WANG, YONG;ZHAO, LIWEN;XU, XIN;ZHANG, XIAN;WANG, DEZHONG;ZHOU, HAIPING;CHEN, HONGYAN;ZHANG, DI;ZHANG, CANG |